MORRIS PLAINS, N.J., May 10, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company is scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference at 12 noon on Thursday, May 17, 2012, at the Encore at Wynn in Las Vegas, NV. The presentation, which can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf, will provide a corporate overview.
